The Coming Cystic Fibrosis Gene Therapy Clinical Trial Supply Conundrum
Gene therapies are coming, and they are coming fast! That’s in part because Vertex has proven the...
Read Moreby Gunnar Esiason | Feb 23, 2023 | Health Policy
Gene therapies are coming, and they are coming fast! That’s in part because Vertex has proven the...
Read Moreby Gunnar Esiason | Dec 6, 2022 | Health Policy
It’s been a while since I’ve blogged… my website is under construction, so I’ve tried to stay off...
Read Moreby Gunnar Esiason | Aug 9, 2022 | Health Policy
TLDR; if you’re a Medicare beneficiary and have a drug for your indication that is on brand, this...
Read Moreby Gunnar Esiason | Jul 12, 2022 | Health Policy, Today in Medicine
If you’ve followed my blog for the last year or so, you’ve seen that I’ve been repeatedly...
Read Moreby Gunnar Esiason | Jan 24, 2022 | Health Policy, Today in Medicine
If Mark Cuban’s Cost Plus Drug Company (yes, that’s literally the name) can be sustained, it might...
Read Moreby Gunnar Esiason | Jan 12, 2022 | Health Policy
Let’s talk about out-of-pocket costs, or OOP’s. We all confront them when we receive healthcare,...
Read Moreby Gunnar Esiason | Nov 11, 2021 | Health Policy
Drug pricing reform is charging through congress, and like anything else in Washington, our...
Read Moreby Gunnar Esiason | Sep 23, 2021 | Business School, Health Policy
Venture Philanthropy in biotechnology is as close to a patient-centered investment thesis as there...
Read Moreby Gunnar Esiason | Aug 30, 2021 | Health Policy, What Am I Reading?
Let’s take a look at my browsing history (No, I don’t subscribe to print newspapers…)! Tom...
Read Moreby Gunnar Esiason | Aug 27, 2021 | Coronavirus, Health Policy, Today in Medicine
Anytime I hear (or see) someone talking about the Pfizer or Moderna vaccines as if they are...
Read Moreby Gunnar Esiason | Aug 23, 2021 | Health Policy, What Am I Reading?
Alright, team! I am going to try something new on the blog. One of the most fundamental parts of...
Read Moreby Gunnar Esiason | Apr 14, 2021 | Health Policy, Today in Medicine
The answer: A LOT. I decided to do some very rough back-of-the-napkin math to understand spending...
Read More*Nothing contained in these blog posts, podcasts, images, or any other posts should be considered medical advice. Such advice can only be given by a physician who is experienced with cystic fibrosis. The contributors on this blog/podcast cannot be held responsible for any damage which may result from using the information on this blog/podcast without permission of their medical doctor. Furthermore, the views expressed on this blog are solely those of the contributors and do not represent the views or opinions of the writer’s employer(s) unless explicitly mentioned.